At the PMSA annual conference, Axtria’s Sudeep Saha and Celgene’s Jennifer Maurer shared an approach that demonstrated how to use patient-level data in a robust way to estimate market opportunity and product penetration in the field of Oncology.
The presentation highlighted some key aspects of the approach/analytics including:
A specific application of this approach was used for an oncology drug that is indicated for 3 different tumor types and a specific treatment regimen within each tumor type. The presenters showcased how patient-level data from Rx and medical claims, can be used to develop an approach for estimating market opportunity and product penetration at an account level for Oncology products.
To learn more about the presentation, reach out to us at insights@axtria.com.